3,208 Followers on Owler

Merz

Merz researches, develops and markets pharmaceuticals for the treatment of neurological and psychiatric diseases. Read more

Philip Burchard's photo - CEO of Merz

CEO

Philip Burchard

CEO Approval Rating

90/100

Founded:

1908

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

MERZ TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Allergan is Merz's #1 competitor. Allergan is a Private company that was founded in 1948 in Coolock, County Dublin. Allergan is in the Health Care Supplies industry. Compared to Merz, Allergan has 13,749 more employees.

Galderma is seen as one of Merz's biggest rivals. Galderma was founded in La Tour-de-Peilz, Vaud} in 1981. Galderma competes in the Health Care Services field. Compared to Merz, Galderma generates $1.9B more revenue.

Ipsen Pharma is one of Merz's top competitors. Ipsen Pharma is headquartered in Boulogne-Billancourt, Other, and was founded in 1929. Ipsen Pharma is in the Pharmaceuticals field. Ipsen Pharma generates 240% the revenue of Merz.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 3,151 a good estimate for Merz's Employee count?

Merz Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
ON Light Sciences

Aug 2016

Source »
undisclosed
ON Light Sciences is the developer of DeScribe Transparent PFD Patch for tattoo removal.
Ulthera, Inc.

Jun 2014

Source »
$600M
Ulthera provides an ultrasound based medical technology treatments.
Anteis S.A.

Nov 2013

Source »
undisclosed
-

These are all the companies that Merz has acquired. Merz has acquired 3 companies and its latest acquisition was ON Light Sciences in Aug 2016. ON Light Sciences is the developer of DeScribe Transparent PFD Patch for tattoo removal.

Merz Funding History

No recent funding data found related to Merz

Merz Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Cytrellis Biosystems is a medical technology company that develops esthetic devices for anti-aging skin treatment.
$28.5M
Jun 04, 2018
Series B
-
Cytrellis Biosystems is a medical technology company that develops esthetic devices for anti-aging skin treatment.
-
Apr 26, 2016
Equity
-

These are all the companies that Merz has invested in. Merz has invested 3 companies and its latest investment was ON Light Sciences in Aug 2016. ON Light Sciences is the developer of DeScribe Transparent PFD Patch for tattoo removal.

Merz News

December 18, 2020FinanzNachrichten

Merz Healthcare Breaks Even Despite COVID-19 Pandemic in Fiscal Year 2019/20

Net consolidated operating profit of the Frankfurt family business amounts to EUR 38.8 million Partne... See more »
September 16, 2020FiercePharma

Merz signs actress and lifestyle maven Paltrow as new face of aesthetic injection Xeomin

Merz signs actress and lifestyle maven Paltrow as new face of aesthetic injection Xeomin bbulik Wed, ... See more »
June 29, 2020State of Affairs

Teijin Receives Marketing Approval for Merz's Xeomin Botulinum Toxin Type A in Japan

Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA... See more »
November 15, 2019FiercePharma

Merz splits into 3 businesses for better customer focus

Merz, going for a strong customer focus, recently did something many of its pharma peers have done: s... See more »
November 13, 2019The Business Journals: Raleigh/Durham

Why Merz tapped Raleigh as global HQ for its aesthetics business

The new CEO of Merz's global aesthetics business says Raleigh was a natural choice for a company look... See more »
November 13, 2019The Pharma Letter

Merz splits into three with vow to target US medical aesthetics market

Privately-held German group Merz has announced plans to reorganize into three independently operating... See more »
November 12, 2019FinanzNachrichten

Merz to Create Three Independent, Customer-Focused Healthcare Businesses to Drive Growth

New organizational structure planned to strengthen customer focus and drive sustainable growth Merz n... See more »

Merz Press Releases

May 13, 2019Business Wire

FDA Approves Broadened Indication for XEOMIN® (IncobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administrat... See more »
March 3, 2019PRWeb

Patients Release Their Inner Butterfly at Innovative New Scottsdale Medspa

On March 5th at 11:30 Rinuva MD Holdings and the Scottsdale Chamber of Commerce will cut the ribbon a... See more »
June 5, 2018Business Wire

Merz Venture Initiative Increases Investment in Cytrellis

FRANKFURT, Germany--(BUSINESS WIRE)--#aestheticmedicine--Merz, a global leader in medical aesthetics ... See more »
December 26, 2016Blackbird

Global Cosmetic Surgery Market to grow at a CAGR of 6.80% during Forecast period 2016-2020

Albany, NY, Dec 26: Cosmetic surgery is a procedure carried out to improve the appearance of specific... See more »
December 25, 2016ePress Release

U.S. Scar Treatment Market Trends, Size, Share, Development and Demand Forecast to 2020

The U S scar treatment market is growing, owing to the increasing prevalence of skin problems leading... See more »
December 9, 2016openPR

Global Cosmetic Surgery Market to grow at a CAGR of 6.80% during 2016-2020

About Cosmetic Surgery Cosmetic surgery is a procedure carried out to improve the appearance of speci... See more »

Social Media

Merz Headquarters

Eckenheimer Landstrasse 100

Frankfurt, Hesse60318

49-69-1503-0

Driving Directions »

Trending Companies

Merz Summary

ABOUT

Overview

Merz researches, develops and markets pharmaceuticals for the treatment of neurological and psychiatric diseases. Merz was founded in 1908. Merz's headquarters is located in Frankfurt, Hesse, DE 60318. Merz's latest acquisitions include ON Light Scien...

CEO

Merz's CEO, Philip Burchard, currently has an approval rating of 90%. Merz's primary competitors are Allergan, Galderma & Ipsen Pharma.

Website

merz.com

Frequently Asked Questions about Merz

  1. When was Merz founded?

    Merz was founded in 1908
  2. Who is Merz's CEO?

    Merz's CEO is Philip Burchard
  3. How much revenue does Merz generate?

    Merz generates $1.2B in revenue
  4. How much funding does Merz have?

    Merz has historically raised $0 in funding
  1. Where is Merz's headquarters?

    Merz's headquarters is in Frankfurt Hesse, DE
  2. How many employees does Merz have?

    Merz has 3,151 employees
  3. Who are Merz's competitors?

    Merz's top competitors are Allergan, Galderma, Ipsen Pharma
  4. Who has Merz invested in?

    Merz's has invested in companies such as Cytrellis Biosystems, Cytrellis Biosystems